🔎 Trials Near Me

Hjem › Smolderende multippel myelom › New York

Kliniske studier for Smolderende multippel myelom i New York

8 studier for Smolderende multippel myelom søker deltakere på steder i New York.

Byer i New York

Offisiell studietekst (engelsk)

A Study to Compare Linvoseltamab and Daratumumab Treatment in High-Risk Smoldering Multiple Myeloma (HR-SMM)

  • Memorial Sloan Kettering Cancer Center, New York
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 25. sep. 2026 · NCT07393282

Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma

  • Hematology Oncology Associates of CNY at Camillus, Camillus
  • Hematology Oncology Associates of Central New York-East Syracuse, East Syracuse
  • Mount Sinai Chelsea, New York
  • og 2 flere
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 19. aug. 2026 · NCT03937635

A Proof-of-Concept Study to Learn Whether Linvoseltamab Can Eliminate Abnormal Plasma Cells That May Lead to Multiple Myeloma in Adult Patients With High-Risk Monoclonal Gammopathy of Undetermined Significance or Non-High-Risk Smoldering Multiple Myeloma

  • NYU Langone Health Perlmutter Cancer Center, New York
  • Stony Brook University Hospital, Stony Brook
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 8. jul. 2026 · NCT06140524

A Study Comparing a Plant-Based Diet With Supplements and Placebo in People With Monoclonal Gammopathy of Undetermined Significance (MGUS) or Smoldering Multiple Myeloma (SMM)

  • Memorial Sloan Kettering Suffolk- Commack (All Protocol Activities), Commack
  • Memorial Sloan Kettering Westchester (All Protocol Activities), Harrison
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
  • og 1 flere
Rekrutterer
Alder 18 og eldre · Alle kjønn · Oppdatert 16. apr. 2026 · NCT05640843

Non-chemotherapeutic Interventions for the Improvement of Quality of Life and Immune Function in Patients With Multiple Myeloma

  • Roswell Park Cancer Institute, Buffalo
Rekrutterer
Alder 18 og eldre · Alle kjønn · Oppdatert 1. des. 2025 · NCT05312255

A Study of a Plant-Based Diet and Dietary Supplements in People With Smoldering Multiple Myeloma (SMM) or Monoclonal Gammopathy of Undetermined Significance (MGUS)

  • Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities), Commack
  • Memorial Sloan Kettering Westchester (All Protocol Activities), Harrison
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
  • og 1 flere
Rekrutterer
Alder 18 og eldre · Alle kjønn · Oppdatert 13. nov. 2025 · NCT06055894

Screening for AL Amyloidosis in Smoldering Multiple Myeloma

  • Columbia University Irving Medical Center, New York
  • Memorial Sloan Kettering Cancer Center, New York
RekruttererObservasjonsstudie
Alder 40 og eldre · Alle kjønn · Oppdatert 6. aug. 2025 · NCT06365060

Selinexor for the Treatment of Intermediate and High-Risk Smoldering Multiple Myeloma

  • University of Rochester, Rochester
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 10. feb. 2025 · NCT05597345

Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.